UniProt Q72498
Integrase (Q72498)
Integrase (UniProt Q72498): 47 experimental structures on GenesisL1, 2 ligands bound. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- Q72498
- Protein
- Integrase
- Experimental structures
- 47
- Predicted models
- 0
- Ligands
- 2
Structures
47 records of Q72498 in the MolNFT archive: 47 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1K6Y | Crystal Structure of a Two-Domain Fragment of HIV-1 Integrase | x-ray diffraction | A, B, C, D | — | — |
| 1K6Y | Crystal structure of a two-domain fragment of HIV-1 integrase | x-ray diffraction | A, B, C, D | — | — |
| 3AO1 | Fragment-based approach to the design of ligands targeting a novel site in HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3AO1 | Fragment-based approach to the design of ligands targeting a novel site in HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3AO2 | Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3AO2 | Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3AO3 | Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3AO3 | Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3AO4 | Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3AO4 | Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3AO5 | Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3AO5 | Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3L3U | Crystal structure of the HIV-1 integrase core domain to 1.4A | x-ray diffraction | A, B | — | — |
| 3L3U | Crystal structure of the HIV-1 integrase core domain to 1.4A | x-ray diffraction | A, B | — | — |
| 3L3V | Structure of HIV-1 integrase core domain in complex with sucrose | x-ray diffraction | A, B | — | — |
| 3L3V | Structure of HIV-1 integrase core domain in complex with sucrose | x-ray diffraction | A, B | — | — |
| 3OVN | Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3OVN | Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3VQ4 | Fragments bound to HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3VQ4 | Fragments bound to HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 3VQ5 | HIV-1 IN core domain in complex with N-METHYL-1-(4-METHYL-2-PHENYL-1,3-THIAZOL-5-YL)METHANAMINE | x-ray diffraction | A, B | — | — |
| 3VQ5 | HIV-1 in core domain in complex with N-methyl-1-(4-methyl-2-phenyl-1, 3-thiazol-5-YL)METHANAMINE | x-ray diffraction | A, B | — | — |
| 3VQ6 | HIV-1 IN core domain in complex with (1-methyl-5-phenyl-1H-pyrazol-4-yl)methanol | x-ray diffraction | A, B | — | — |
| 3VQ6 | HIV-1 in core domain in complex with (1-methyl-5-phenyl-1H-pyrazol-4- YL)METHANOL | x-ray diffraction | A, B | — | — |
| 3VQ7 | HIV-1 IN core domain in complex with 4-(1H-pyrrol-1-yl)aniline | x-ray diffraction | A, B | — | — |
| 3VQ7 | HIV-1 in core domain in complex with 4-(1H-pyrrol-1-YL)ANILINE | x-ray diffraction | A, B | — | — |
| 3VQ8 | HIV-1 IN core domain in complex with (3R)-3,4-dihydro-2H-chromen-3-ylmethanol | x-ray diffraction | A, B | — | — |
| 3VQ8 | HIV-1 in core domain in complex with (3R)-3,4-dihydro-2H-chromen-3- ylmethanol | x-ray diffraction | A, B | — | — |
| 3VQ9 | HIV-1 IN core domain in complex with 6-fluoro-1,3-benzothiazol-2-amine | x-ray diffraction | A, B, C | — | — |
| 3VQ9 | HIV-1 in core domain in complex with 6-fluoro-1,3-benzothiazol-2-amine | x-ray diffraction | A, B, C | — | — |
| 3VQA | HIV-1 IN core domain in complex with 1-benzothiophen-6-amine 1,1-dioxide | x-ray diffraction | A, B | — | — |
| 3VQA | HIV-1 in core domain in complex with 1-benzothiophen-6-amine 1,1- dioxide | x-ray diffraction | A, B | — | — |
| 3VQB | HIV-1 IN core domain in complex with 6-fluoro-4H-1,3-benzodioxine-8-carboxylic acid | x-ray diffraction | A, B | — | — |
| 3VQB | HIV-1 in core domain in complex with 6-fluoro-4H-1,3-benzodioxine-8- carboxylic acid | x-ray diffraction | A, B | — | — |
| 3VQC | HIV-1 IN core domain in complex with (5-METHYL-3-PHENYL-1,2-OXAZOL-4-YL)METHANOL | x-ray diffraction | A, B | — | — |
| 3VQC | HIV-1 in core domain in complex with (5-methyl-3-phenyl-1,2-oxazol-4- YL)METHANOL | x-ray diffraction | A, B | — | — |
| 3VQD | HIV-1 IN core domain in complex with 5-methyl-3-phenyl-1,2-oxazole-4-carboxylic acid | x-ray diffraction | A, B | — | — |
| 3VQD | HIV-1 in core domain in complex with 5-methyl-3-phenyl-1,2-oxazole-4- carboxylic acid | x-ray diffraction | A, B | — | — |
| 3VQE | HIV-1 IN core domain in complex with [1-(4-fluorophenyl)-5-methyl-1H-pyrazol-4-yl]methanol | x-ray diffraction | A, B | — | — |
| 3VQE | HIV-1 in core domain in complex with [1-(4-fluorophenyl)-5-methyl-1H- pyrazol-4-YL]METHANOL | x-ray diffraction | A, B | — | — |
| 3VQP | HIV-1 IN core domain in complex with 2,3-dihydro-1,4-benzodioxin-5-ylmethanol | x-ray diffraction | A, B | — | — |
| 3VQP | HIV-1 in core domain in complex with 2,3-dihydro-1,4-benzodioxin-5- ylmethanol | x-ray diffraction | A, B | — | — |
| 3VQQ | HIV-1 integrase core domain in complex with 2,1,3-benzothiadiazol-4-amine | x-ray diffraction | A, B | — | — |
| 3VQQ | HIV-1 integrase core domain in complex with 2,1,3-benzothiadiazol-4- amine | x-ray diffraction | A, B | — | — |
| 5HOT | Structural Basis for Inhibitor-Induced Aggregation of HIV-1 Integrase | x-ray diffraction | A, B | 2SQ | — |
| 5HOT | Structural basis for inhibitor-induced aggregation of HIV-1 integrase | x-ray diffraction | A, B | — | — |
| 8CT5 | Catalytic Core Domain of HIV-1 Integrase (F185K) | x-ray diffraction | A | SO4 | — |
Ligands
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.